The Pennant Group, Inc. (NASDAQ:PNTG - Get Free Report)'s share price hit a new 52-week high during mid-day trading on Thursday . The stock traded as high as $42.74 and last traded at $41.4730, with a volume of 40786 shares trading hands. The stock had previously closed at $42.48.
Analyst Upgrades and Downgrades
A number of research analysts recently commented on the company. Royal Bank Of Canada increased their target price on The Pennant Group from $42.00 to $44.00 and gave the company an "outperform" rating in a research note on Thursday, August 20th. Weiss Ratings upgraded The Pennant Group from a "buy (b-)" rating to a "buy (b)" rating in a research report on Wednesday, August 19th. Wells Fargo & Company boosted their price objective on shares of The Pennant Group from $45.00 to $46.00 and gave the stock an "overweight" rating in a report on Tuesday, August 11th. Truist Financial upped their price objective on shares of The Pennant Group from $42.00 to $48.00 and gave the company a "buy" rating in a research note on Tuesday, July 14th. Finally, Wall Street Zen raised shares of The Pennant Group from a "hold" rating to a "buy" rating in a report on Saturday, June 20th. Seven research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $41.60.
View Our Latest Report on The Pennant Group
The Pennant Group Trading Down 3.6%
The firm has a market cap of $1.43 billion, a PE ratio of 45.51, a PEG ratio of 2.61 and a beta of 1.27. The firm has a fifty day simple moving average of $39.54 and a two-hundred day simple moving average of $35.34. The company has a current ratio of 1.20, a quick ratio of 1.20 and a debt-to-equity ratio of 0.48.
The Pennant Group (NASDAQ:PNTG - Get Free Report) last released its quarterly earnings results on Wednesday, August 5th. The company reported $0.36 earnings per share for the quarter, beating the consensus estimate of $0.33 by $0.03. The Pennant Group had a net margin of 2.93% and a return on equity of 10.33%. The business had revenue of $297.98 million for the quarter, compared to analysts' expectations of $288.71 million. The Pennant Group has set its FY 2026 guidance at 1.340-1.410 EPS. Equities analysts forecast that The Pennant Group, Inc. will post 1.18 EPS for the current year.
Institutional Investors Weigh In On The Pennant Group
Several hedge funds have recently made changes to their positions in PNTG. BlackRock Inc. purchased a new stake in The Pennant Group during the 2nd quarter valued at $109,340,000. Wasatch Advisors LP lifted its holdings in shares of The Pennant Group by 31.8% during the second quarter. Wasatch Advisors LP now owns 1,870,178 shares of the company's stock valued at $69,103,000 after purchasing an additional 451,491 shares in the last quarter. Paradigm Capital Management Inc. NY purchased a new stake in shares of The Pennant Group during the second quarter valued at $51,833,000. Turtle Creek Asset Management Inc. increased its holdings in The Pennant Group by 12,075.6% in the 1st quarter. Turtle Creek Asset Management Inc. now owns 1,582,823 shares of the company's stock worth $48,244,000 after buying an additional 1,569,823 shares in the last quarter. Finally, Dimensional Fund Advisors LP raised its position in The Pennant Group by 1.5% in the 1st quarter. Dimensional Fund Advisors LP now owns 815,660 shares of the company's stock worth $24,861,000 after buying an additional 11,943 shares during the last quarter. 85.88% of the stock is currently owned by institutional investors.
About The Pennant Group
(
Get Free Report)
The Pennant Group, Inc is a healthcare services company that operates home health, hospice and personal care businesses, as well as senior living communities. Its services are designed to support older adults and other patients in their homes, residential settings and communities, with offerings that may include skilled nursing, therapy, hospice care, assisted living and memory care.
The company serves patients and residents through a network of affiliated operating companies and communities across multiple U.S.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider The Pennant Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and The Pennant Group wasn't on the list.
While The Pennant Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.